Katalin Karikó
Department of Neurosurgery
University of Pennsylvania
Room 371 Stemmler Hall
36th & Hamilton Walk
USA
Name/email consistency: high
- Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Karikó, K., Muramatsu, H., Welsh, F.A., Ludwig, J., Kato, H., Akira, S., Weissman, D. Mol. Ther. (2008)
- Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development. Karikó, K., Weissman, D. Curr. Opin. Drug. Discov. Devel (2007)
- Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Karikó, K., Buckstein, M., Ni, H., Weissman, D. Immunity (2005)
- mRNA is an endogenous ligand for Toll-like receptor 3. Karikó, K., Ni, H., Capodici, J., Lamphier, M., Weissman, D. J. Biol. Chem. (2004)
- Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance. Karikó, K., Weissman, D., Welsh, F.A. J. Cereb. Blood Flow Metab. (2004)
- In vivo protein expression from mRNA delivered into adult rat brain. Karikó, K., Keller, J.M., Harris, V.A., Langer, D.J., Welsh, F.A. J. Neurosci. Methods (2001)
- Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA. Karikó, K., Kuo, A., Barnathan, E.S., Langer, D.J. Biochim. Biophys. Acta (1998)